[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fSE80XNAmAk0Z8x2gUJN9keDEcpZaeWHjpAXxLn-VNmQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":46,"rows":53},"Universitat Internacional de Catalunya",[4],147,false,32,1,11553,2,138,[14,17,20,23,26,28,31,33],{"name":15,"count":16},"Peri-Implantitis",12,{"name":18,"count":19},"Peri-implant Mucositis",8,{"name":21,"count":22},"Dental Implant",5,{"name":24,"count":25},"Stroke",4,{"name":27,"count":25},"Gingival Recession",{"name":29,"count":30},"Peri-implantitis",3,{"name":32,"count":30},"Sarcopenia",{"name":34,"count":30},"Neuromuscular Diseases",[36,41],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06504888","Do Penicillin-allergic Patients Presents a High Risk of Sinus Lift Failure","2024-12-31","Penicillin",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT07464197","Effectiveness of Dental Bleaching Using Different Designs of 3D-Printed and Conventional Customized Nightguards","2026-05","Carbamide peroxide 10%",[47,48,49,50,51,52],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[54,79,100,127,157,175,206,224,242,270,288,306,331,358],{"intervention":45,"totalTrials":9,"cells":55},{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":65,"NA":67},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":58},[],{"trials":66,"activeCount":58},[],{"trials":68,"activeCount":9,"soonestReadout":44},[69],{"nctId":42,"briefTitle":43,"status":70,"phases":71,"primaryCompletion":44,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":78},"RECRUITING",[52],"2026-07","2022-05-01",40,[76,77],"Tooth Discoloration","Tooth Staining",[45],{"intervention":40,"totalTrials":9,"cells":80},{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":91},{"trials":82,"activeCount":58},[],{"trials":84,"activeCount":58},[],{"trials":86,"activeCount":58},[],{"trials":88,"activeCount":58},[],{"trials":90,"activeCount":58},[],{"trials":92,"activeCount":9,"soonestReadout":39},[93],{"nctId":37,"briefTitle":38,"status":70,"phases":94,"primaryCompletion":39,"completion":39,"start":95,"enrollment":96,"conditions":97,"interventions":99},[],"2004-07-01",400,[98],"Maxillary Sinus Disease",[40],{"intervention":101,"totalTrials":9,"cells":102},"Probiotic",{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":111,"NA":125},{"trials":104,"activeCount":58},[],{"trials":106,"activeCount":58},[],{"trials":108,"activeCount":58},[],{"trials":110,"activeCount":58},[],{"trials":112,"activeCount":58},[113],{"nctId":114,"briefTitle":115,"status":116,"phases":117,"primaryCompletion":118,"completion":119,"start":120,"enrollment":121,"conditions":122,"interventions":124},"NCT03047291","Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis","COMPLETED",[51],"2017-03-01","2017-09-01","2014-01-01",44,[123,29],"Mucositis",[101],{"trials":126,"activeCount":58},[],{"intervention":128,"totalTrials":9,"cells":129},"Amoxicillin Clavulanate",{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":155},{"trials":131,"activeCount":58},[],{"trials":133,"activeCount":58},[],{"trials":135,"activeCount":58},[],{"trials":137,"activeCount":58},[],{"trials":139,"activeCount":58},[140],{"nctId":141,"briefTitle":142,"status":116,"phases":143,"primaryCompletion":144,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":153},"NCT03574090","Study the Efficacy of Topical Antibiotherapy in the Prophylaxis of Incisional Surgical Infection in Colorectal Surgery",[51],"2023-05-30","2023-06-11","2020-10-20",268,[149,150,151,152],"Surgical Wound Infection","Postoperative Wound Infection","Postoperative Wound Infection Superficial Incisional","Preventive Therapy",[128,154],"Physiological Saline",{"trials":156,"activeCount":58},[],{"intervention":154,"totalTrials":9,"cells":158},{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":165,"PHASE4":167,"NA":173},{"trials":160,"activeCount":58},[],{"trials":162,"activeCount":58},[],{"trials":164,"activeCount":58},[],{"trials":166,"activeCount":58},[],{"trials":168,"activeCount":58},[169],{"nctId":141,"briefTitle":142,"status":116,"phases":170,"primaryCompletion":144,"completion":145,"start":146,"enrollment":147,"conditions":171,"interventions":172},[51],[149,150,151,152],[128,154],{"trials":174,"activeCount":58},[],{"intervention":176,"totalTrials":9,"cells":177},"Melatonin 10 MG Oral",{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":202,"NA":204},{"trials":179,"activeCount":58},[],{"trials":181,"activeCount":58},[],{"trials":183,"activeCount":58},[],{"trials":185,"activeCount":58},[186],{"nctId":187,"briefTitle":188,"status":189,"phases":190,"primaryCompletion":191,"completion":39,"start":192,"enrollment":193,"conditions":194,"interventions":199},"NCT05536596","Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy","UNKNOWN",[49,50],"2024-06-30","2022-09-30",220,[195,196,197,198],"Retrognathism","Prognathism","Orthognathic Surgery","Neurosensory Disorder",[176,200,201],"Hydroxycobalamin","Centrum",{"trials":203,"activeCount":58},[],{"trials":205,"activeCount":58},[],{"intervention":200,"totalTrials":9,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":220,"NA":222},{"trials":209,"activeCount":58},[],{"trials":211,"activeCount":58},[],{"trials":213,"activeCount":58},[],{"trials":215,"activeCount":58},[216],{"nctId":187,"briefTitle":188,"status":189,"phases":217,"primaryCompletion":191,"completion":39,"start":192,"enrollment":193,"conditions":218,"interventions":219},[49,50],[195,196,197,198],[176,200,201],{"trials":221,"activeCount":58},[],{"trials":223,"activeCount":58},[],{"intervention":201,"totalTrials":9,"cells":225},{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":238,"NA":240},{"trials":227,"activeCount":58},[],{"trials":229,"activeCount":58},[],{"trials":231,"activeCount":58},[],{"trials":233,"activeCount":58},[234],{"nctId":187,"briefTitle":188,"status":189,"phases":235,"primaryCompletion":191,"completion":39,"start":192,"enrollment":193,"conditions":236,"interventions":237},[49,50],[195,196,197,198],[176,200,201],{"trials":239,"activeCount":58},[],{"trials":241,"activeCount":58},[],{"intervention":243,"totalTrials":9,"cells":244},"0.12%NF",{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":264,"PHASE4":266,"NA":268},{"trials":246,"activeCount":58},[],{"trials":248,"activeCount":58},[],{"trials":250,"activeCount":58},[251],{"nctId":252,"briefTitle":253,"status":116,"phases":254,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":258,"interventions":261},"NCT02194023","Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.",[49],"2013-07","2011-09",200,[259,260],"Dental Plaque","Side Effects",[243,262,263],"0.03%NF","PAT",{"trials":265,"activeCount":58},[],{"trials":267,"activeCount":58},[],{"trials":269,"activeCount":58},[],{"intervention":262,"totalTrials":9,"cells":271},{"EARLY_PHASE1":272,"PHASE1":274,"PHASE2":276,"PHASE3":282,"PHASE4":284,"NA":286},{"trials":273,"activeCount":58},[],{"trials":275,"activeCount":58},[],{"trials":277,"activeCount":58},[278],{"nctId":252,"briefTitle":253,"status":116,"phases":279,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":280,"interventions":281},[49],[259,260],[243,262,263],{"trials":283,"activeCount":58},[],{"trials":285,"activeCount":58},[],{"trials":287,"activeCount":58},[],{"intervention":263,"totalTrials":9,"cells":289},{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":300,"PHASE4":302,"NA":304},{"trials":291,"activeCount":58},[],{"trials":293,"activeCount":58},[],{"trials":295,"activeCount":58},[296],{"nctId":252,"briefTitle":253,"status":116,"phases":297,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":298,"interventions":299},[49],[259,260],[243,262,263],{"trials":301,"activeCount":58},[],{"trials":303,"activeCount":58},[],{"trials":305,"activeCount":58},[],{"intervention":307,"totalTrials":9,"cells":308},"The effect of tetracycline in degradation and permeability of collagen membranes.",{"EARLY_PHASE1":309,"PHASE1":311,"PHASE2":313,"PHASE3":325,"PHASE4":327,"NA":329},{"trials":310,"activeCount":58},[],{"trials":312,"activeCount":58},[],{"trials":314,"activeCount":58},[315],{"nctId":316,"briefTitle":317,"status":116,"phases":318,"primaryCompletion":319,"start":320,"enrollment":321,"conditions":322,"interventions":324},"NCT02057926","The Effect of Tetracycline in Degradation and Permeability of Collagen Membrane",[49],"2011-11","2009-11",10,[323],"Ridge Preservation Technique",[307],{"trials":326,"activeCount":58},[],{"trials":328,"activeCount":58},[],{"trials":330,"activeCount":58},[],{"intervention":332,"totalTrials":9,"cells":333},"Focal Muscle Vibration",{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":344},{"trials":335,"activeCount":58},[],{"trials":337,"activeCount":58},[],{"trials":339,"activeCount":58},[],{"trials":341,"activeCount":58},[],{"trials":343,"activeCount":58},[],{"trials":345,"activeCount":58},[346],{"nctId":347,"briefTitle":348,"status":116,"phases":349,"primaryCompletion":350,"completion":351,"start":352,"enrollment":74,"conditions":353,"interventions":357},"NCT07049809","Targeting Sarcopenia and Frailty: Multicomponent Exercise With Focal Muscle Vibration",[52],"2025-09-26","2025-12-15","2025-07-02",[32,354,355,356],"Frailty at Older Adults","Cognitive Impairment","Adherence",[332],{"intervention":359,"totalTrials":9,"cells":360},"GV-328",{"EARLY_PHASE1":361,"PHASE1":363,"PHASE2":365,"PHASE3":367,"PHASE4":369,"NA":371},{"trials":362,"activeCount":58},[],{"trials":364,"activeCount":58},[],{"trials":366,"activeCount":58},[],{"trials":368,"activeCount":58},[],{"trials":370,"activeCount":58},[],{"trials":372,"activeCount":58},[373],{"nctId":374,"briefTitle":375,"status":116,"phases":376,"primaryCompletion":377,"completion":377,"start":378,"enrollment":379,"conditions":380,"interventions":382},"NCT04677062","Safety, Galenic Acceptability and Efficacy of GV-328 Lozenges in Children With Oral Aphthosis",[52],"2019-06-30","2017-11-01",33,[381],"Aphthous Stomatitis",[359]]